Skip to main content

Table 1 Summary of treatment groups

From: Diabetes is accompanied by secretion of pro-atherosclerotic exosomes from vascular smooth muscle cells

Group

Exosome source

Diabetic status of VSMC source

Pre-treatment of VSMC

Cell studies

 Ctrl

PBS

  

 NVE

HCASMCs

Non-Diabetic

Non-targeting oligo

 NVE+KD

HCASMCs

Non-Diabetic

miR-221/222 siRNA

 DVE

HCASMCs

Diabetic

Non-targeting oligo

 DVE+KD

HCASMCs

Diabetic

miR-221/222 siRNA

Animal study

 Ctrl

Saline

  

 NVE

NONcNZO10 murine VSMCs

Non-Diabetic

None

 DVE

NONcNZO10 murine VSMCs

Diabetic

None

  1. VSMC: Vascular smooth muscle cell; Ctrl: Control; PBS: Phosphate buffered saline; HCASMCs: Human coronary artery smooth muscle cells; NVE: Non-diabetic VSMC derived exosome; DVE: Diabetic VSMC derived exosome; +KD: miR-221/222 knockdown